MAPK9 and breast cancer: We demonstrate that Sp1 is a critical factor in regulating mmp‐2 transcription in our experimental setting, and RhoGDIβ, via inhibition of miR‐200c, increase in JNK2 protein translation, and Sp1 activity for promotion of BC invasion (Fig. 7F).